Pomegra Newswire

Healthcare News

Healthcare, pharma, and biotech market news: drug approvals, trial results, and the deals reshaping the sector.

All Markets Economy Business & Earnings Technology Healthcare Policy & Regulation Geopolitics Community & Media

McKesson Buys Precision Medicine Group for $2.25B

Healthcare

MAJOR

1d ago6 min read

McKesson Buys Precision Medicine Group for $2.25B

McKesson Corporation

Medline Soars 40% in Record $5.26B Nasdaq Debut

Healthcare

SEISMIC

1d ago6 min read

Medline Soars 40% in Record $5.26B Nasdaq Debut

Medline Industries

VEEV Surges 18% as Q2 FY2027 Earnings Crush Forecasts

Healthcare

MAJOR

2d ago6 min read

VEEV Surges 18% as Q2 FY2027 Earnings Crush Forecasts

Veeva Systems

BSX Stock Falls 5% as Cyberattack and Recall Collide

Healthcare

MAJOR

3d ago5 min read

BSX Stock Falls 5% as Cyberattack and Recall Collide

Boston Scientific

Pharma's $134B M&A Wave: Buyout Freeze Declared Over

Healthcare

MAJOR

4d ago7 min read

Pharma's $134B M&A Wave: Buyout Freeze Declared Over

AbbVie

Merck Surges 12% on Landmark Melanoma Vaccine Win

Healthcare

SEISMIC

6d ago6 min read

Merck Surges 12% on Landmark Melanoma Vaccine Win

Merck & Co.

MRNA Surges 177% on mRNA Cancer Vaccine Trial Win

Healthcare

SEISMIC

6d ago5 min read

MRNA Surges 177% on mRNA Cancer Vaccine Trial Win

biotech company stocks

Capricor Surges 86% on Lancet DMD Trial Data, FDA Signals Path Forward

Healthcare

MAJOR

Aug 146 min read

Capricor Surges 86% on Lancet DMD Trial Data, FDA Signals Path Forward

Capricor Therapeutics

Moderna mFLUSIVA: FDA Clears First mRNA Flu Shot

Healthcare

MAJOR

Aug 65 min read

Moderna mFLUSIVA: FDA Clears First mRNA Flu Shot

Moderna

Replimune Surges After FDA Panel Backs RP1 Melanoma Drug

Healthcare

Aug 16 min read

Replimune Surges After FDA Panel Backs RP1 Melanoma Drug

IGNYTE

Abivax $920M Raise Funds Solo U.S. Drug Launch

Healthcare

Jul 115 min read

Abivax $920M Raise Funds Solo U.S. Drug Launch

Abivax S.A.

TRIMTECH Therapeutics Closes $47M Seed Round With JJDC Backing

Healthcare

Jun 245 min read

TRIMTECH Therapeutics Closes $47M Seed Round With JJDC Backing

Cambridge biotech TRIMTECH Therapeutics extended its seed round by $14M, bringing total funding to $47M, with J&J Innovation's JJDC and BGF co-leading to advance novel protein degradation therapies fo...

Jazz Pharma Drops as Lung Cancer Drug Misses Goals

Healthcare

Jun 125 min read

Jazz Pharma Drops as Lung Cancer Drug Misses Goals

Jazz Pharmaceuticals

LLY's Retatrutide Hits 28.3% Weight Loss in Phase 3

Healthcare

Jun 16 min read

LLY's Retatrutide Hits 28.3% Weight Loss in Phase 3

Eli Lilly and Company

Why is healthcare news different?

Healthcare investing runs on binary events. A drug trial readout or an FDA approval decision can double a biotech or cut it in half overnight, because a small company's whole valuation may rest on one molecule. The desk covers those catalysts - trial results, approvals, and the label details that decide a drug's market - alongside the steadier earnings of large pharma, insurers, and device makers.

The sector is also the classic defensive play: people need medicine in every economy, so healthcare earnings hold up when cyclical sectors roll over. Coverage links each story to the wiki entries on the science terms and the sector mechanics, so a headline about a Phase 3 miss explains itself.

Frequently Asked

Why are biotech stocks so volatile?

Small biotech valuations often rest on one or two drug candidates, so trial results and FDA decisions can reprice the whole company overnight.